Aging in epidermal melanocytes: Cell cycle genes and melanins

Journal of Investigative Dermatology Symposium Proceedings

Volumn 3, Issue 1, 1998, Pages 36-40

  Haddad, Mäher M ^a   Xu, Weidong ^a   Medrano, Estela E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cell cycle; Differentiation; Human melanocytes

Indexed keywords

ALPHA INTERMEDIN; CYCLIC AMP; CYCLIN DEPENDENT KINASE INHIBITOR; HISTONE; MELANIN; PROTEIN P16; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR E2F;

ACETYLATION; AGING; CANCER INHIBITION; CELL AGGREGATION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN STRUCTURE; CONFERENCE PAPER; ENZYME BINDING; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; LENTIGO; MELANOCYTE; NEVUS CELL; NONHUMAN;

EID: 0031754561     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1038/jidsymp.1998.9     Document Type: Conference Paper

References (58)

1. Abdel-Malek Z, Swope VB, Pallas J, Krug K, Nordlund JJ: Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens.J Cell Physiol 150:416-425, 1992
2. Abdel-Malek Z, Swope VB, Nordlund JJ, Medrano EE: Proliferation and propagation of human melanocytes in vitro are affected by donor age and anatomical site, Pigment CW/K7:116-122, 1994
3. Abdel-Malek Z, Swope VB, Susuki I, et al: Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Xatl Acad Sci (USA) 92:1789-1793, 1995
4. Aso M, Hashimoto K, Eto H, Fukaya T, Ishihara M, Shimao S, Shimizu Y: Expression of Schwärm cell characteristics in pigmented nevus. Immunohistochemical study using monoclonal antibody to Schwann cell associated antigen. Cancer 62:938-943, 1988
5. Bennett DC: Differentiation in mouse melanoma cells: initial reversibility and an on-off" stochastic model. Cell 34:445-453, 1983
6. Der Rahman S, Bhawan J: Lentigo. IntJ Dcnnatol 35:229-393, 1996
7. Campisi J: Replicarive senescence: an old lives' tale? Cell 84:497-500, 1996
8. Chakarborty A, Slominski A, Ermak G, Hwang J, Pawelek JM: Ultraviolet B and melanocyte-stimulation hormone (MSH) stimulate niRNA production for aMSH receptors and proopiomelanocortin-dtfrived peptides in mouse melanoma cells and transformed keratinocytes. J Invest Dennjtol 105:655-659, 1995
9. Clark WH Jr, Elder DE, Guerry D, Epstein MM. Greene MH, Van Horn M: A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Human Pathol 15:1147-1165, 1984
10. DeGregoriJ, Leone G, Miron A, Jakoi L, NevinsJR:. Distinct roles for E2F proteins in cell growth control and apoptosis. Prof Xatl AcjJ Sci (USA) 94:7245-7250, 1997
11. Dimri GP, Lee X, Basile G, ff al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Nail Acad Sci (USA) 92:9363-9367, 1995
12. Ellis NA: Mutation-causing mutations, Nature 381:110-111, 1996
13. Farooqui JZ, Medrano EE, Abdel-Malek Z, Nordlund J: The expression of proopiomelanocortin and various POMC-derived peptides in mouse and human skin. Ann New York Acad Sd 680:508-510, 1993
14. Fitzpatrick TB, Szabo G, Mitchell R: Age changes in the human melanocyte system. In: Montagna W (ed.). Advances in the Biology of the Skin, Vol. VI. Pergamon Press, Oxford, 1964, pp 35-50
15. Furumura M, Sakai C, Abdel-Malek Z, Barsh GS, Hearing VJ: The interaction of agouti signal protein and melanocyte stimulating hormone to regulate melanin formation in mammals. Pigment Cell Res 9:191-203, 1996
16. Gilchrest BA, Blog FB, Szabo G: Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dennatot 73:141-143, 1979
17. Gilchrest BA, Karassik RL, Wilkins LM, Vrabel MA, Maciag T: Autocrine and paracrine growth stimulation of cells derived from human skin. J Cell Physiol 117:235-240,1983
18. Gilchrest BA, Vrabel MA, Flynn E, Szabo G: Selective cultivation of human melanocytes. from newborn and adult epidermis. J Invest Dcnnatol 83:370-376, 1984
19. Gilhar A, Pillar T, David M, Eidelman S: Melanocytes and Langerhans cells in aged versus young skin before and after transplantation onto nude mice. J Invest Dennatol 96:210-214, 1991
20. Goto M, Miller RW, Ishikawa Y, Sugano H: Excess of rare cancers in Wemer syndrome (adult progeria). Cancer Epidcmiol, Biomarkers Prevention 5:239-246, 1996
21. Graeven U, Herlyn M: In vitro growth patterns of normal human mehnocytes and melanocytes from different stages of melanoma progression. Itnmtmothcrapy 12:199-202, 1992
22. Gu W, Roeder RG: Activation of p53 sequence-specific DNA binding by Acetylation of the p53 c-temiinal domain. Cell 90:595-606, 1997
23. Guerra L, Dover L, Mordoh J: Differentiating effect of L-tyrosine on the human melanoma cell line IIB-MEL-J. Exptl Cell Res 183:61-65, 1990
24. Halaban R, Langdon R, Birchall N, et al: Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 107:1611-1619, 1988
25. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G: Regulation of p6CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16:859-867, 1996
26. Hauser PJ, Agrawal D, Flanagan M, Pledger WJ: The role of p27kipl in the in vitro differentiation of murine keratinocytes. Cell C/wit/i Di/f 8:203-211, 1997
27. Hayflick L: The cell biology of aging. Invest Dcnnatol 73 (1):8-14, 1979
28. Hearing VJ: Regulation of melanin fomiation. In: Nordlund et al (eds). Tlie Pigmentary Systems and its Disorders. Oxford University Press, Oxford, 423-138, 1998
29. Herlyn M, Mancianti ML, Jambrosic J, Bolen JD, Koprowski H: Regulatory factors that determine growth and phenotype of normal human melanocytes. Expl Cell Res 179:322-331, 1988
30. Herzberg AJ, Dinehardt SM: Chronological aging in black skin. Am J Dcrmaopathol 11:319-328, 1989
31. Hosoda K, Hammer RE, Richardson JA, Grecnstein Baynash A, Cheung JA, Giaid A, Yanagisawa M: Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267-1276, 1994
32. Hu F: Aging Melanocytes. Im-est Dermatol 73:70-793, 1979
33. Hunt G, Todd C, Thody AJ:. Unresponsiveness of human epidermal melanocytes to melanocyte-stimularing hormone and its association with red hair. Mol Cell Endocrinol 116:131-136, 1996
34. Luger TA, Scholzen T, Grabbe S: The role of a-melanocyte-stimulating hormone in cutaneous biology. J Im-est Dermatol 2:87-93, 1997
35. Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Florenes VA: Cyclin kinase inhibitor p21WAFl/CIPl in malignant melanoma: reduced expression in metastatic lesions. /)myP/ioM49:1813-1822, 1996
36. Medrano EE, Yang F, Boissy R, et ah Terminal differentiation and senescence in the human melanocyte: repression of tyrosinc-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes. AM Biol Cell 5:497-509, 1994
37. Montagna W, Carlisle K: Structural changes in ageing skin. Br J Dcrmatol 122 (Suppl. 35):61-70, 1990
38. Murphy M, Reid Dutton K, Brookcr R, Bardett G: Neural stem cells PF. Invest Dermatol 2:8-13, 1997
39. Nakajima T, Uchida C, Anderson SF, Lee CG, Hurwitz J, Parvin JD, Montminy M: RNA helicase a mediater Association of CBP with RNA polymerase II. Cell 90:1107-1112, 1997
40. NordlundJJ: The lives of pigment cells. Dermatologie Clinics 4:407-418, 1986
41. Ogryzko VV, Hirai TH, Russanova VR, Barbie DA, Howard BH: Human fibroblast commitment to a senescence-like swte in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol 16:5210-5218, 1996
42. Ortonne JP: Pigmentary changes of the ageing skin. Br J Dermaol 122 (Suppl. 35):21-28, 1990
43. Rieber M, Rieber MS: Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation. Cell Growth DiJ5:1339-1346, 1994
44. Sherr CJ, Roberts JM: Inhibitors of mammalian Gl Cyclin-dependent kinases. Cm Dcv 9:1149-1163, 1995
45. Sidle A, Palary C, Dirks P, et al: Activity of the retinoblastoma family proteins, pRB, p07, and p0, during cellular proliferation and differentiation. Crit Rev Biocliem Mot Biol 31:237-271. 1996
46. Smith EJ, Leone G, DeGregori J, Jakoi L, NevinsJR:. The accumulation of an E2F-pl30 transcriptional represser distinguishes a GO cell state from a Gl cell state. AfW Cell Biol 16:6965-6976, 1996
47. Smith JR, Pereira-Smith OM: Replicative senescence: implications for in vivo aging and tumor suppression. Science 273:63-67, 1996
48. Snell RS, Bischitz PG: The melanocytes and melanin in human abdominal wall skin, a survey made at different ages in both sexes and during pregnancy. J Anal 97:361-376, 1963
49. Staricco RF, Pinkus H: Quantitative and qualitative data on the pigment cells of adult human epidermis. J Im-est Dematol 28:33-45, 1957
50. Szabo G: The number of melanoccytes in human epidermis. BrMeJJ 1:1016-1017, 1954
51. Takada K, Sugiyama K, Yamamoto I, Oba K, Akeuchi TT: Presence of amelanotic melanocytes within the outer root sheath in senile white hair. J Invest Dermatol 99:629-633, 1992
52. Tassabehji M, Newton VE, Read AP: Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nature Genet 8:251-255, 1994
53. Trotter M, Tang L, Tron V: Overexpression of the cyclin-dependent kinase inhibitor p21WAFl/CIPl in human cutaneous malignant melonoma. J Cutaneous Pathol 24:265-27'1, 1997
54. Valverde P, Healy Sikking E, Haldane S, Thody F, Carothers AJ, Jackson A, Rees IJ: The As84Glu variant of the melanocortin receptor (MC1R) is associated with melanoma. Hum Mol Genet 5:1663-1666, 1996
55. Wade PA, Wolffe AP: Chromatin: Histone acetyltransferases in control. Current Biol 2:82-84, 1997
56. West MD: The cellular and molecular biology of skin aging. Arch Dermatol 130:87-95, 1994
57. West MD, Shay JW, Wright WE, Linskens MH: Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Expl Cerontol 31:175-193, 1996
58. Yu CE, Oshima J, Fu YH, et al: Positional cloning of the Werner's syndrome gene. Science 272:258-262, 1996